Cart
sales@molnova.com
SIRT1-IN-1
CAS No. 352554-02-0
SIRT1-IN-1( —— )
Catalog No. M28822 CAS No. 352554-02-0
SIRT1-IN-1 is a selective inhibitor of SIRT1 with an IC50 of 205 nM. SIRT1-IN-1 is an inhibitor of cytomegalovirus (CMV) with antiviral activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 202 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 534 | In Stock |
|
| 50MG | 732 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | 1330 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSIRT1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSIRT1-IN-1 is a selective inhibitor of SIRT1 with an IC50 of 205 nM. SIRT1-IN-1 is an inhibitor of cytomegalovirus (CMV) with antiviral activity.
-
DescriptionSIRT1-IN-1 is a selective inhibitor of SIRT1 with an IC50 of 205 nM. SIRT1-IN-1 is an inhibitor of cytomegalovirus (CMV) with antiviral activity.(In Vitro):SIRT1-IN-1 inhibits SIRT2 with an IC50 of 11.5 μM. SIRT1-IN-1 has little effect on SIRT3 (IC50>100 μM) and HDAC (IC50>100 μM).
-
In VitroSIRT1-IN-1 (compound 2) has little effect on SIRT3 (IC50>100 μM) and HDAC (IC50>100 μM).
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
Recptorosteoclastogenesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number352554-02-0
-
Formula Weight228.29
-
Molecular FormulaC14H16N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (438.04 mM)
-
SMILESO=C(N)C1C=2NC=3C=CC(=CC3C2CCC1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.OSCOTEC INC; KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; OCT - US2008/221205, 2008, A1
molnova catalog
related products
-
Antiviral agent 34
Antiviral agent 34 is an orally available, potent antiviral compound that inhibits influenza A and B viruses.
-
Tyrosine kinase-IN-7
Tyrosine kinase-IN-7 is a potent inhibitor of the tyrosine kinase EGFR, inhibiting EGFR(WT) and EGFR(T790M) and showing anti-cancer and anti-tumor activity in a variety of cancer cell lines.
-
ITMN4077
ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
